Please use this identifier to cite or link to this item:
https://observatorio.fm.usp.br/handle/OPI/1282
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor | Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP | - |
dc.contributor.author | DANILOVIC, Alexandre | - |
dc.contributor.author | LOPES, Roberto Iglesias | - |
dc.contributor.author | SANCHES, Talita Rojas | - |
dc.contributor.author | SHIMIZU, Maria Heloisa Massola | - |
dc.contributor.author | OSHIRO, Fabiola M. | - |
dc.contributor.author | ANDRADE, Lucia | - |
dc.contributor.author | DENES, Francisco Tibor | - |
dc.contributor.author | SEGURO, Antonio Carlos | - |
dc.date.accessioned | 2013-07-30T17:17:35Z | - |
dc.date.available | 2013-07-30T17:17:35Z | - |
dc.date.issued | 2012 | - |
dc.identifier.citation | UROLOGY, v.80, n.2, article ID 485.e15, 6p, 2012 | - |
dc.identifier.issn | 0090-4295 | - |
dc.identifier.uri | https://observatorio.fm.usp.br/handle/OPI/1282 | - |
dc.description.abstract | OBJECTIVE To assess the effects of atorvastatin (ATORV) on renal function after bilateral ureteral obstruction (BUO), measuring inulin clearance and its effect on renal hemodynamic, filtration, and inflammatory response, as well as the expression of Aquaporin-2 (AQP2) in response to BUO and after the release of BUO. METHODS Adult Munich-Wistar male rats were subjected to BUO for 24 hours and monitored during the following 48 hours. Rats were divided into 5 groups: sham operated (n = 6); sham + ATORV (n = 6); BUO (n = 6); BUO + ATORV (10 mg/kg in drinking water started 2 days before BUO [n = 5]; and BUO + ATORV (10 mg/kg in drinking water started on the day of the release of BUO [n = 5]). We measured blood pressure (BP, mm Hg); inulin clearance (glomerular filtration rate [GFR]; mL/min/100 g); and renal blood flow (RBF, mL/min, by transient-time flowmeter). Inflammatory response was evaluated by histologic analysis of the interstitial area. AQP2 expression was evaluated by electrophoresis and immunoblotting. RESULTS Renal function was preserved by ATORV treatment, even if initiated on the day of obstruction release, as expressed by GFR, measured by inulin clearance. Relative interstitial area was decreased in both BUO + ATORV groups. Urine osmolality was improved in the ATORV-treated groups. AQP2 protein expression decreased in BUO animals and was reverted by ATORV treatment. CONCLUSION ATORV administration significantly prevented and restored impairment in GFR and renal vascular resistance. Furthermore, ATORV also improved urinary concentration by reversing the BUO-induced downregulation of AQP2. These findings have significant clinical implication in treating obstructive nephropathy. UROLOGY 80: 485.e15-485.e20, 2012. (c) 2012 Elsevier Inc. | - |
dc.language.iso | eng | - |
dc.publisher | ELSEVIER SCIENCE INC | - |
dc.relation.ispartof | Urology | - |
dc.rights | restrictedAccess | - |
dc.subject.other | atrial-natriuretic-peptide | - |
dc.subject.other | water channels | - |
dc.subject.other | expression | - |
dc.subject.other | transporters | - |
dc.subject.other | nephropathy | - |
dc.subject.other | inhibition | - |
dc.subject.other | diuresis | - |
dc.subject.other | fibrosis | - |
dc.subject.other | failure | - |
dc.title | Atorvastatin Prevents the Downregulation of Aquaporin-2 Receptor After Bilateral Ureteral Obstruction and Protects Renal Function in a Rat Model | - |
dc.type | article | - |
dc.rights.holder | Copyright ELSEVIER SCIENCE INC | - |
dc.identifier.doi | 10.1016/j.urology.2012.02.021 | - |
dc.identifier.pmid | 22503765 | - |
dc.subject.wos | Urology & Nephrology | - |
dc.type.category | original article | - |
dc.type.version | publishedVersion | - |
hcfmusp.description.articlenumber | 485.e15 | - |
hcfmusp.description.issue | 2 | - |
hcfmusp.description.volume | 80 | - |
hcfmusp.origem | WOS | - |
hcfmusp.origem.id | 2-s2.0-84864628163 | - |
hcfmusp.origem.id | WOS:000307244200082 | - |
hcfmusp.publisher.city | NEW YORK | - |
hcfmusp.publisher.country | USA | - |
hcfmusp.relation.reference | Angulo JC, 2010, UROLOGY, V76, P301, DOI 10.1016/j.urology.2009.12.002 | - |
hcfmusp.relation.reference | Danilovic A, 2005, INT BRAZ J UROL, V31, P436 | - |
hcfmusp.relation.reference | Danilovic Alexandre, 2005, Int Braz J Urol, V31, P431 | - |
hcfmusp.relation.reference | Epstein M, 2005, AM J KIDNEY DIS, V45, P2, DOI 10.1053/j.ajkd.2004.08.040 | - |
hcfmusp.relation.reference | Frokiaer J, 1996, AM J PHYSIOL-RENAL, V270, pF657 | - |
hcfmusp.relation.reference | Gordon Morris, 2007, Urology, V69, DOI 10.1016/j.urology.2007.01.022 | - |
hcfmusp.relation.reference | GULMI FA, 1995, J UROLOGY, V153, P1276, DOI 10.1016/S0022-5347(01)67585-2 | - |
hcfmusp.relation.reference | Jensen AM, 2009, AM J PHYSIOL-RENAL, V296, pF127, DOI 10.1152/ajprenal.90479.2008 | - |
hcfmusp.relation.reference | Jensen AM, 2006, AM J PHYSIOL-RENAL, V291, pF1021, DOI 10.1152/ajprenal.00387.2005 | - |
hcfmusp.relation.reference | Kamdar C, 2010, UROLOGY, V75, P853, DOI 10.1016/j.urology.2009.05.030 | - |
hcfmusp.relation.reference | KAUKER ML, 1992, NEPHRON, V60, P281 | - |
hcfmusp.relation.reference | Kim SW, 2001, J AM SOC NEPHROL, V12, P2019 | - |
hcfmusp.relation.reference | Klahr S, 2002, AM J PHYSIOL-RENAL, V283, pF861, DOI 10.1152/ajprenal.00362.2001 | - |
hcfmusp.relation.reference | Kuwabara N, 2006, UROLOGY, V67, P440, DOI 10.1016/j.urology.2005.09.028 | - |
hcfmusp.relation.reference | Li CL, 2003, AM J PHYSIOL-RENAL, V284, pF155, DOI 10.1152/ajprenal.00272.2002 | - |
hcfmusp.relation.reference | Li CL, 2001, AM J PHYSIOL-RENAL, V281, pF163 | - |
hcfmusp.relation.reference | Liano F, 1996, KIDNEY INT, V50, P811, DOI 10.1038/ki.1996.380 | - |
hcfmusp.relation.reference | Vaughan E Darracott Jr, 2004, J Urol, V172, P2563, DOI 10.1097/01.ju.0000144286.53562.95 | - |
hcfmusp.relation.reference | Matsuda H, 2011, UROLOGY, V77, pe249 | - |
hcfmusp.relation.reference | Michli E, 2007, J UROLOGY, V177, P781, DOI 10.1016/j.juro.2006.09.078 | - |
hcfmusp.relation.reference | Murer L, 2004, J AM SOC NEPHROL, V15, P2705, DOI 10.1097/01.ASN.0000139689.94776.7A | - |
hcfmusp.relation.reference | MURPHY GP, 1966, J UROLOGY, V95, P636 | - |
hcfmusp.relation.reference | Norregaard R, 2005, AM J PHYSIOL-RENAL, V289, pF322, DOI 10.1152/ajprenal.00061.2005 | - |
hcfmusp.relation.reference | Puri TS, 2010, AM J PHYSIOL-RENAL, V298, pF1024, DOI 10.1152/ajprenal.00384.2009 | - |
hcfmusp.relation.reference | REYES AA, 1991, P SOC EXP BIOL MED, V197, P49 | - |
hcfmusp.relation.reference | Ryndin I, 2005, J UROLOGY, V173, P651, DOI 10.1097/01.ju.0000150532.61780.1f | - |
hcfmusp.relation.reference | Shimizu MHM, 2008, NEPHROL DIAL TRANSPL, V23, P3067, DOI 10.1093/ndt/gfn237 | - |
hcfmusp.relation.reference | Shokeir AA, 2002, UROLOGY, V59, P506, DOI 10.1016/S0090-4295(01)01623-5 | - |
hcfmusp.relation.reference | Yang SX, 2010, J ENDOUROL, V24, P1721, DOI 10.1089/end.2009.0420 | - |
hcfmusp.relation.reference | Yano Y, 2009, AM J PHYSIOL-RENAL, V296, pF54, DOI 10.1152/ajprenal.90367.2008 | - |
hcfmusp.relation.reference | Yao Y, 2011, UROLOGY, V77, pe768 | - |
dc.description.index | MEDLINE | - |
hcfmusp.lim.ref | 2012 | - |
hcfmusp.citation.scopus | 7 | - |
hcfmusp.scopus.lastupdate | 2024-04-12 | - |
Appears in Collections: | Artigos e Materiais de Revistas Científicas - FM/MCM Artigos e Materiais de Revistas Científicas - HC/ICHC Artigos e Materiais de Revistas Científicas - LIM/12 Artigos e Materiais de Revistas Científicas - LIM/55 |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
art_DANILOVIC_Atorvastatin_Prevents_the_Downregulation_of_Aquaporin_2_Receptor_2012.PDF Restricted Access | publishedVersion (English) | 1.01 MB | Adobe PDF | View/Open Request a copy |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.